Jazz Pharmaceuticals plc (JAZZ) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Core Insights - Jazz Pharmaceuticals participated in the Citi Annual Global Healthcare Conference, highlighting its presence in the biopharma sector [1] - Philip Johnson, Executive VP and CFO of Jazz Pharmaceuticals, introduced new team members and emphasized the importance of investor relations [2] Company Overview - Jazz Pharmaceuticals is actively engaging with investors and stakeholders at industry conferences to enhance visibility and communication [1][2] - The company has recently appointed John Bluth as the new Head of Investor Relations, indicating a focus on strengthening investor engagement [2] Financial Guidance - The discussion referenced guidance from the November 6, 3Q earnings call, suggesting that the company is maintaining transparency regarding its financial outlook [3]